Loading...
Loading...
MCK| Name | Value |
|---|---|
| Revenues | 74.5B |
| Cost of Revenue | 71.5B |
| Gross Profit | 3.0B |
| Operating Expense | 1.9B |
| Operating I/L | 1.1B |
| Other Income/Expense | -0.0B |
| Interest Income | 0.0B |
| Pretax | 1.1B |
| Income Tax Expense | 0.1B |
| Net Income/Loss | 1.0B |
McKesson Corporation operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions. The U.S. Pharmaceutical segment distributes a wide range of pharmaceutical drugs and healthcare products, offering practice management, technology, and business solutions to specialty practices. The International segment provides distribution and services to wholesale, institutional, and retail customers in multiple countries. The Medical-Surgical Solutions segment offers medical-surgical supply distribution and logistics to healthcare providers. The RxTS segment serves biopharma and life sciences partners, connecting pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions.
